Spasticity News and Research

RSS
Spasticity is a condition involving an involuntary increase in muscle tone that leads to resistance against normal movements of the body and may cause pain in some individuals.
Miami Project to Cure Paralysis receives FDA permission to begin Phase 1 trial

Miami Project to Cure Paralysis receives FDA permission to begin Phase 1 trial

Paralympic medicine: challenges and rewards

Paralympic medicine: challenges and rewards

Smoked cannabis may be an effective treatment for spasticity

Smoked cannabis may be an effective treatment for spasticity

XenoPort first quarter revenues increase to $10.4 million

XenoPort first quarter revenues increase to $10.4 million

Intronix launches Myoguide Needle EMG Guided Injection System

Intronix launches Myoguide Needle EMG Guided Injection System

Concert, Fast Forward partner to advance new approach to treat spasticity and pain in MS

Concert, Fast Forward partner to advance new approach to treat spasticity and pain in MS

Watson, Acorda partner to introduce tizanidine hydrochloride capsules

Watson, Acorda partner to introduce tizanidine hydrochloride capsules

UofL, Frazier Rehab to establish Spinal Cord Injury Model System

UofL, Frazier Rehab to establish Spinal Cord Injury Model System

Reversing low VEGF levels may potentially treat patients with SCA1

Reversing low VEGF levels may potentially treat patients with SCA1

Scuba diving linked to improved PTSD symptoms in veterans with spinal cord injuries

Scuba diving linked to improved PTSD symptoms in veterans with spinal cord injuries

Children and adults with social withdrawal due to Fragile X may benefit from STX209

Children and adults with social withdrawal due to Fragile X may benefit from STX209

Scientists probe 'atlastin,' a protein linked to hereditary spastic paraplegia

Scientists probe 'atlastin,' a protein linked to hereditary spastic paraplegia

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

Israeli scientists identify genetic cause of hereditary spastic paraparesis

Israeli scientists identify genetic cause of hereditary spastic paraparesis

Study: Marijuana use may affect cognitive skills in patients with MS

Study: Marijuana use may affect cognitive skills in patients with MS

New Pediatric Physical Medicine and Rehabilitation Service at NewYork-Presbyterian Hospital

New Pediatric Physical Medicine and Rehabilitation Service at NewYork-Presbyterian Hospital

XenoPort reports preliminary top-line results from arbaclofen placarbil Phase 2b clinical trial in GERD

XenoPort reports preliminary top-line results from arbaclofen placarbil Phase 2b clinical trial in GERD

Benefits and underutilization of ITB therapy for multiple sclerosis

Benefits and underutilization of ITB therapy for multiple sclerosis

Exciting progress made in MS research during 2010

Exciting progress made in MS research during 2010